UK Pharma Industry

Companies developing AI and ML for pharmaceutical R&D.

Companies that automate pharmaceutical and biopharma manufacturing and research.

Companies providing data, analytics tools and services, including real-world evidence datasets and analytics to support pharmaceutical R&D.

Companies developing novel formulation and drug delivery technologies to improve bioavailability, release profile and route of administration.

Companies that develop or manufacture their own medicines, including generics of established molecules or innovator drugs.

Companies mainly involved in developing human-relevant, non-traditional preclinical testing technologies.

Companies that tailor disease prevention and treatment to the specific characteristics, such as genetics and biomarkers, of individual patients.

Companies developing therapeutics for rare, orphan or underserved diseases with small patient populations.

Not-for-profit and academic-linked institutes, catapults and centres that provide shared facilities, infrastructure and expertise to accelerate drug discovery and research.

Companies that develop and provide specialised software and platforms for the pharmaceutical sector.

Companies developing therapeutics that act on a specific molecular target, pathway or mechanism.